Vitale, Antonella

Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. [electronic resource] - Haematologica Mar 2007 - 342-8 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.10385 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antigens, CD--biosynthesis
Antigens, Differentiation, Myelomonocytic--biosynthesis
Antigens, Neoplasm--biosynthesis
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Blood Cell Count
Burkitt Lymphoma--blood
CD13 Antigens--biosynthesis
Cell Lineage
Cohort Studies
Combined Modality Therapy
Cranial Irradiation
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Disease-Free Survival
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Female
Humans
Immunophenotyping
Leukemia-Lymphoma, Adult T-Cell--blood
Male
Middle Aged
Multicenter Studies as Topic--statistics & numerical data
Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood
Prognosis
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic--statistics & numerical data
Remission Induction
Sialic Acid Binding Ig-like Lectin 3